Previous Chapter: 4 Treatment Implications of Biomarkers
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 33
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 34
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 35
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 36
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 37
Suggested Citation: "5 Challenges and Opportunities." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13146.
Page 38
Next Chapter: Appendix A: References
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.